
Abaloparatide3 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Abaloparatide, explained simply
An analogue of parathyroid hormone-related peptide studied for its effects on bone. Clinical findings concern controlled pharmaceutical formulations.
Research area
Bone formation and density
How it works
Acts at the PTH1 receptor and stimulates processes involved in new bone formation.
Why it matters
It is primarily relevant to research on skeletal health and osteoporosis.
What has been observed
Human studies of controlled pharmaceutical products have documented effects on bone density and fracture risk.
Effects and points to consider
Results from an approved formulation do not establish the quality, equivalence or use of a reconstituted vial described on this page.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 3 mg Abaloparatide |
|---|---|
| Final volume | 3 mL |
| Concentration | 1 mg/mL |
| One U-100 unit | 10 mcg in 0.01 mL |
One-Vial Calculation Using the Human-Study Daily Amount
| Research Period | Amount per Administration | U-100 Units (mL) |
|---|---|---|
| 37 daily administrations (one-vial arithmetic) | 80 mcg | 8 units (0.08 mL) |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.